3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
6
Surgical Wound Infection
4
Pilonidal Sinus
3
Wound Infection
2
Spinal Cord Injuries
1
Skin Neoplasms
1
Skin Carcinoma
1
Seroma
1
Sarcoma
1
Postoperative Complications
1
Obesity
1
Non-melanoma Skin Cancer
1
Neoplasm Metastasis
1
Infections
1
Adenocarcinoma
1
Interventions
pembrolizumab
3
Ipilimumab
3
Educational Status
3
Biopsy
3
Optical Imaging
2
Nivolumab
2
Early Intervention, Educational
2
Ascorbic Acid
2
methyl 5-aminolevulinate
1
lavender oil
1
four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate)
1
fludarabine phosphate
1
fludarabine
1
aldesleukin
1
Zinc
1
Water
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Tomography, Optical Coherence
1
Toll-Like Receptor 1
1
Tea
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Spermine Synthase
1
Specimen Handling
1
Semaxinib
1
Second Harmonic Generation Microscopy
1
Risk Factors
1
Resistance Training
1
Radiotherapy, Image-Guided
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Skin Neoplasms
×
Negative-Pressure Wound Therapy
×
Clear all
NCT07040683
2026-05-28
LEGS
Region Skane
Phase NA
Recruiting
242 enrolled